MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Erythromycin + Zinc acetate

Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion

No stability information

Stability notes for Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion

There are no stability notes for this medicine.

Suppliers (6) of Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion
Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion (Alliance Healthcare (Distribution) Ltd)
Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion (Neon Healthcare Ltd)
Zineryt lotion (CST Pharma Ltd)
Zineryt lotion (Lexon (UK) Ltd)
Zineryt lotion (Necessity Supplies Ltd)
Zineryt lotion (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.